693287-94-4 Usage
Ethyl ester derivative
It is derived from 4-hydrazino-1-piperidinecarboxylic acid by attaching an ethyl ester group, which may increase its lipid solubility and absorption in biological systems.
Hydrazine derivative
The presence of a nitrogen-nitrogen bond classifies 1-Piperidinecarboxylicacid,4-hydrazino-,ethylester(9CI) as a hydrazine derivative, which is known for its various biological activities.
Biological activities
Hydrazine derivatives, including 1-Piperidinecarboxylicacid,4-hydrazino-,ethylester(9CI), have been found to exhibit antimicrobial, anticancer, and antiviral properties.
Potential applications
Due to its hydrazine derivative nature and ethyl ester group, 1-Piperidinecarboxylic acid, 4-hydrazino-, ethyl ester (9CI) may be useful in the synthesis of pharmaceuticals and agrochemicals, as well as in drug delivery applications.
Further research needed
More studies are required to fully understand the potential uses and effects of 1-Piperidinecarboxylicacid,4-hydrazino-,ethylester(9CI) in various fields of chemistry and pharmacology.
Check Digit Verification of cas no
The CAS Registry Mumber 693287-94-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,9,3,2,8 and 7 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 693287-94:
(8*6)+(7*9)+(6*3)+(5*2)+(4*8)+(3*7)+(2*9)+(1*4)=214
214 % 10 = 4
So 693287-94-4 is a valid CAS Registry Number.
693287-94-4Relevant academic research and scientific papers
THIAZOLIDINE DERIVATIVE AND MEDICINAL USE THEREOF
-
Page 43, (2010/02/07)
A thiazolidine derivative represented by the formula (I) wherein each symbol is as defined in the specification, and a pharmaceutically acceptable salt thereof exhibit a potent DPP-IV inhibitory activity, and can be provided as an agent for the prophylaxis or treatment of diabetes, an agent for the prophylaxis or treatment of obesity and the like.
Synthesis and Selective Cyclooxygenase-2 Inhibitory Activity of a Series of Novel, Nitric Oxide Donor-Containing Pyrazoles
Ranatunge, Ramani R.,Augustyniak, Michael,Bandarage, Upul K.,Earl, Richard A.,Ellis, James L.,Garvey, David S.,Janero, David R.,Letts, L. Gordon,Martino, Allison M.,Murty, Madhavi G.,Richardson, Stewart K.,Schroeder, Joseph D.,Shumway, Matthew J.,Tam, S. William,Trocha, A. Mark,Young, Delano V.
, p. 2180 - 2193 (2007/10/03)
The synthesis of a series of novel pyrazoles containing a nitrate (ONO 2) moiety as a nitric oxide (NO)-donor functionality is reported. Their COX-1 and COX-2 inhibitory activities in human whole blood are profiled. Our data demonstrate that py
